1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Molybdenum Cofactor Deficiency, Complementation Group A: new trials by email Literature Review of Molybdenum Cofactor Deficiency, Complementation Group A trials Research Report on Molybdenum Cofactor Deficiency, Complementation Group A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A cPMP - Molybdenum Cofactor Deficiency Type A | Phase 1 / Phase 2 | Withdrawn | Orphatech Pharmaceuticals, GmbH | 10 | 2009-08-01 | 2011-02-01 |
molybdopterin synthase (1) · nulibry (1)
Orphatech Pharmaceuticals, GmbH (1)
Australia (1)
Alex Veldman, MD (1)